Risk of de novo hepatocellular carcinoma following use of direct acting antiviral medications for treatment of chronic hepatitis C

Samuel O. Antwi, Holly K. Van Houten, Lindsey R. Sangaralingham, Tushar Patel

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Risk of de novo hepatocellular carcinoma following use of direct acting antiviral medications for treatment of chronic hepatitis C'. Together they form a unique fingerprint.

Medicine & Life Sciences